Email Alert Subscription

Step 1 of 3: Select Options

In light of Canada's anti-spam legislation (CASL) which came into effect on July 1, 2014, we are required to obtain your express consent to send you commercial electronic messages. If you wish to receive electronic communications from us, please indicate your consent by checking the boxes beside the materials that you wish to receive.

Also, it is important to note that you can withdraw your consent entirely, or modify your email preferences, at any time by clicking here.

Press Releases

SEC Filings


Webcasts and Events

in advance of any event.

Stock Information

Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $3.600
Alert me when the stock changes more than % in one day.

Unsubscribe from Investor Relations email alerts.

Arbutus Biopharma
100-8900 Glenlyon Pkwy
Burnaby, BC V5J 5J8

Our email alerts provide automated opt-out methods as well as complete contact information.